Research output per year
Research output per year
Personal profile
Research areas
Clinical research in diabetic complications, main focus on diabetic nephropathy and cardiovascular disease
clinical trials, biomarker discovery with targeted and untargeted methods
metabolomics in relation to progresion of type 1 and type 2 diabetes, liver disease and diabetic complications
Main research areas
Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics
Current research
Focus on late diabetic complications,
biomarkers predicting risk for initiation or progression of complications,
clinical studies of interventions aiming at preventing or treating complications
improving understanding of pathophysiology of complications
Potential conflicts of interest
•consultancy and/or speaking fees (to institution) from AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk and Sanofi Aventis
•research grants from AstraZeneca Bayer and Novo Nordisk
study medication from Bayer Novo Nordisk Astra Zeneca Lexicon Pharma
External positions
board member, Bagger Sørensen Fonden
2024 → …
member(chair (2024-), Sundhed og Sygdom, Det Frie Forskningsråd
2021 → …
Steno Diabetes Center A/S
… → 2016
Professor in endocrinology with focus on vascular complications, University of Copenhagen
Fingerprint
Dive into the research topics where Peter Rossing is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate
Navaneethan, S. D., Anker, S. D., Filippatos, G., Pitt, B., Rossing, P., Ruilope, L. M., August, P., Brinker, M., Lage, A., Roberts, L., Scott, C., Sarafidis, P. & FIDELIO-DKD, 21 Apr 2025, (E-pub ahead of print) In: Kidney International.Research output: Contribution to journal › Journal article › Research › peer-review
-
Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study
Bahrami, H. S. Z., Jørgensen, P. G., Hove, J. D., Dixen, U., Rasmussen, L. J. H., Eugen-Olsen, J., Rossing, P. & Jensen, M. T., Apr 2025, In: Diabetes Research and Clinical Practice. 222, p. 112071 112071.Research output: Contribution to journal › Journal article › Research › peer-review
-
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations
Brock, C., Andersen, H., Alibegovic, A. C., Andersen, S. T., Andreasen, L. J., Charles, M. H., Christensen, D. H., Drewes, A. M., Gall, M.-A., Gylfadottir, S. S., Hansen, C. S., Hecquet, S. K., Jensen, T. S., Karlsson, P., Knudsen, L. B., Lobato, C. B., Kufaishi, H., Maalmi, H., Mizrak, H. I. & Nilsen, K. B. & 15 others, , 22 Jan 2025, (E-pub ahead of print) In: Diabetes Research and Clinical Practice. 221, p. 112010 112010.Research output: Contribution to journal › Journal article › Research › peer-review
-
Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort
Hansen, A. L., Christiansen, C. F., Brøns, C., Engelhard, L. M., Hansen, T., Nielsen, J. S., Vestergaard, P., Højlund, K., Jessen, N., Olsen, M. H., Sørensen, H. T., Rossing, P., Thomsen, R. W. & Vaag, A., 1 Feb 2025, (E-pub ahead of print) In: Diabetologia.Research output: Contribution to journal › Journal article › Research › peer-review
-
Bone mineral density and the risk of kidney disease in patients with type 1 diabetes
Hauge, S. C., Hjortkjær, H. Ø., Persson, F., Theilade, S., Frost, M., Jørgensen, N. R., Rossing, P. & Hansen, D., Feb 2025, In: Journal of Diabetes and its Complications. 39, 2, 108927.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus)
Prizes
-
-
-
Dandy foundation honorary award
Rossing, P. (Recipient), 2000
Prize: Prizes, scholarships, distinctions
-
-
Novartis Young Investigator Award
Rossing, P. (Recipient), 2008
Prize: Prizes, scholarships, distinctions
Activities
-
-
-
SGLT2 inhibition and Finerenone in Diabetic Kidney Disease
medicine, D. (Lecturer)
4 Dec 2023Activity: Talk or presentation › Lecture and oral contribution
-
Precision Medicine in Diabetes Complications
Rossing, P. (Lecturer)
30 Nov 2023Activity: Talk or presentation › Lecture and oral contribution
-